Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 AUD | -0.66% | -0.44% | -6.22% |
04-30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
04-17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
Sales 2024 * | 297M 194M 266M | Sales 2025 * | 398M 260M 357M | Capitalization | 470M 307M 421M |
---|---|---|---|---|---|
Net income 2024 * | 21M 13.73M 18.82M | Net income 2025 * | 30M 19.61M 26.88M | EV / Sales 2024 * | 1.64 x |
Net Debt 2024 * | 17.01M 11.12M 15.24M | Net Debt 2025 * | 22.65M 14.81M 20.29M | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
24.8
x | P/E ratio 2025 * |
15.4
x | Employees | - |
Yield 2024 * |
2.26% | Yield 2025 * |
3.02% | Free-Float | 69.3% |
Latest transcript on IPD Group Limited
1 day | -0.66% | ||
1 week | -0.44% | ||
Current month | -6.03% | ||
1 month | -4.24% | ||
3 months | -6.61% | ||
6 months | +17.71% | ||
Current year | -6.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-12-31 | |
Jason Boschetti
DFI | Director of Finance/CFO | - | 22-11-27 |
Mohamed Yoosuff
PRN | Corporate Officer/Principal | - | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Moffat
BRD | Director/Board Member | 62 | 20-03-23 |
David Rafter
CHM | Chairman | - | 19-08-13 |
Chief Executive Officer | - | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 4.52 | -0.66% | 52 432 |
24-05-01 | 4.55 | -0.66% | 71,062 |
24-04-30 | 4.58 | -1.29% | 108,819 |
24-04-29 | 4.64 | +0.65% | 97,875 |
24-04-26 | 4.61 | -0.43% | 86,941 |
Delayed Quote Australian S.E., May 02, 2024 at 02:10 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.22% | 306M | |
-5.55% | 7.85B | |
+1.74% | 7.76B | |
+13.01% | 7.32B | |
+6.03% | 1.29B | |
+88.18% | 786M | |
-10.45% | 638M | |
-1.69% | 606M | |
+65.43% | 602M | |
+160.87% | 537M |
- Stock Market
- Equities
- IPG Stock